Study programme 2025-2026Français
Biochimie médicale - Partie 2
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences

CodeTypeHead of UE Department’s
contact details
Teacher(s)
UM-M1-PHARMA-015-MCompulsory UEWOLFF Fleur
  • WOLFF Fleur

Language
of instruction
Language
of assessment
HT(*) HTPE(*) HTPS(*) HR(*) HD(*) CreditsWeighting Term
  • Français
Français33000044.002nd term

AA CodeTeaching Activity (AA) HT(*) HTPE(*) HTPS(*) HR(*) HD(*) Term Weighting
M-DOYM-005Biochimie médicale - Partie 2330000Q2100.00%

Programme component

Objectives of Programme's Learning Outcomes

Learning Outcomes of UE

The student must understand the pathophysiology of different diseases and the utility of assessing biological markers.

UE Content: description and pedagogical relevance

The main objective of this activity is to improve the knowledge of the different fields of clinical biology. This activity is composed of a theoretical part (60h) and a practical laboratory work (50h). The theoretical part (Q2, 33h) will cover the following topics:
8. Renal function
9. Endocrine function
10. Bone and mineral metabolism
11. Lipids and cardiovascular diseases
13. Inflammatory and tumor markers  
14. Basic concepts in hematology

Prior Experience

Basic principles in biochemistry must be understood.

Type of Teaching Activity/Activities

AAType of Teaching Activity/Activities
M-DOYM-005
  • Cours magistraux

Mode of delivery

AAMode of delivery
M-DOYM-005
  • Face-to-face

Required Learning Resources/Tools

AARequired Learning Resources/Tools
M-DOYM-005Documents (pdf format) on the Moodle plateform (http://www.umons.ac.be)

Recommended Learning Resources/Tools

AARecommended Learning Resources/Tools
M-DOYM-005Not applicable

Other Recommended Reading

AAOther Recommended Reading
M-DOYM-005Textbook of Clinical Chemistry and Molecular Diagnostics, Nader Rifai, Andrea Rita Horvath, Carl Wittwer, 6th edition, Elsevier, 2018
en biochimie médicale: interprétations et orientations diagnostiques, 2019, Lavoisier Paris
Biochimie Médicale ; Marqueurs Actuels Et Perspectives, J.L. Beaudeux, G. Durand, 2e édition, 2011
Pathologie générale. Collège universitaire français des pathologistes, Elsevier, 2009

Grade Deferrals of AAs from one year to the next

AAGrade Deferrals of AAs from one year to the next
M-DOYM-005Authorized

Term 2 Assessment - type

AAType(s) and mode(s) of Q2 assessment
M-DOYM-005
  • Written examination - Face-to-face
  • Oral examination - Face-to-face

Term 2 Assessment - comments

AATerm 2 Assessment - comments
M-DOYM-005The understanding of the course will be evaluated. The evaluation will be in written form face-to-face if sanitary conditions allow it (if not the test wil be oral).

Term 3 Assessment - type

AAType(s) and mode(s) of Q3 assessment
M-DOYM-005
  • Written examination - Face-to-face
  • Oral examination - Face-to-face

Term 3 Assessment - comments

AATerm 3 Assessment - comments
M-DOYM-005The understanding of the course will be evaluated. The evaluation will be in written form face-to-face if sanitary conditions allow it (if not the test wil be oral).
(*) HT : Hours of theory - HTPE : Hours of in-class exercices - HTPS : hours of practical work - HD : HMiscellaneous time - HR : Hours of remedial classes. - Per. (Period), Y=Year, Q1=1st term et Q2=2nd term
Date de dernière mise à jour de la fiche ECTS par l'enseignant : 20/05/2025
Date de dernière génération automatique de la page : 14/03/2026
20, place du Parc, B7000 Mons - Belgique
Tél: +32 (0)65 373111
Courriel: info.mons@umons.ac.be